Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease.

Front Med (Lausanne) · 2021 · PMC7969499 · PMID 33748156

Europe PMC DOI

hedged sentence

0.3100

closest p · 6.2× alpha

0.3100

boldest claim

The sentences

failed to reach significancep = 0.31not close (p > 0.1)

Moreover, although their study also found ARB exposure to be associated with lower odds of severe disease, this association failed to reach significance [OR, 0.6 (95% CI 0.27–1.36) p = 0.31].

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.